PCSK9 Inhibitors in the Progression of Aortic Stenosis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.
Also called NCT03051360
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 140 participants
- Registry
-
NCT03051360
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03051360. Randomized; quadruple masking; primary purpose prevention. Start 2017-06-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PCSK9 Inhibitors in the Progression of Aortic Stenosis
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- PCSK9 Inhibitor [EPC]
- Intervention (Drug)
- Placebos
- Lead sponsor
- Seoul National University Hospital
Record details
- Record id
cardio:ct-nct03051360- Content hash
79a879e80445c7f0122b4f82c7d8e6bf4c0b03ba42124027b4d06f55bd0e4ebd